Statistical Analysis Plan for the Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMIST)
Billot, L.; Bompoint, S.; Ouyang, M.; Xu, L.; Wang, X.; Malavera, A.; Johnson, B.; Summers, D.; Khatri, P.; Munoz-Venturelli, P.; Day, D.; Sui, Y.; Song, L.; Wan Zaidi, W. A.; Huy Thang, N.; Delcourt, C.; Robinson, T.; Jan, S.; Lindley, R. I.; Urrutia, V. C.; Anderson, C. S.
Show abstract
1The OPTIMIST trial aims to determine whether low-intensity monitoring is at least as effective ("non-inferior") to standard monitoring, on the functional recovery of patients who have received recombinant tissue plasminogen activator or equivalent lytic reperfusion treatment for acute ischaemic stroke. It is designed as an international, multicenter, stepped-wedge (4 periods/3 steps) cluster randomized trial. This statistical analysis plan pre-specifies the method of analysis for every outcome and key variable collected in the trial. The primary outcome is an "unfavourable outcome" at Day 90, defined as a score of 2 to 6 on the modified Rankin scale. The primary analysis will consist in a log-binomial regression adjusted for the effect of time and for clustering by site using a random effect. The non-inferiority margin was pre-specified as a relative risk of 1.15 for a bad outcome; thus, non-inferiority will be declared if the upper bound of the 95% confidence interval around the relative risk is lower than 1.15. The primary analysis will adjust for calendar time (6-month intervals) and will be based on imputed data. The analysis plan also includes planned sensitivity analyses including covariate adjustments and subgroup analyses. 2 Administrative information2.1 Study identifiersO_LIProtocol Number: GI-AU-NMH-2019-CA Version: 3.0, Date: 3 March 2021 C_LIO_LIClinicalTrials.gov register Identifier: NCT03734640 C_LIO_LIAustralian New Zealand Clinical Trial Registry: ACTRN 12619001556134 C_LI 2.2 Revision history O_TBL View this table: org.highwire.dtl.DTLVardef@27d512org.highwire.dtl.DTLVardef@115cc51org.highwire.dtl.DTLVardef@190ca9org.highwire.dtl.DTLVardef@8e41ddorg.highwire.dtl.DTLVardef@18624dd_HPS_FORMAT_FIGEXP M_TBL C_TBL 2.3 Contributors to the statistical analysis planLB - Main author; developed the initial draft and prepared subsequent versions. SB - Prepared initial draft and reviewed subsequent versions. MO, CA - Reviewed every draft and approved final version. LX - Prepared economic analysis section and approved final version. SJ - Comments on economic analysis plan; approved final draft. XW, AM, BJ, DS, PK, PM-V, DD, YS, LS, WAWZ, NHT, CD, TR, RIL - Approved final draft.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records 95%
- Effectiveness and Cost-Effectiveness of TeleStroke Consultations to Support the Care of Stroke Patients Presenting to Regional Emergency Departments in Western Australia: An Economic Evaluation Case Study Protocol 94%
- CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 94%
Similar papers in this journal
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 95%
- Non-invasive Auricular Vagus nerve stimulation for Subarachnoid Hemorrhage (NAVSaH): Protocol for a prospective, triple-blinded, randomized controlled trial 94%
- Laboratory-confirmed respiratory viral infection triggers for acute myocardial infarction and stroke: systematic review protocol 94%
Similar papers in this journal
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 96%
- Statistical Analysis Plan for the Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN): a study protocol for a stepped-wedge cluster randomized controlled trial 95%
- Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol 94%
Similar papers in this journal
- Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial 92%
- A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health 91%
- Erroneous risks in pharmaceutical versus non-pharmaceutical interventions during data extraction in evidence synthesis practice: Study protocol for a randomized controlled trial 91%
Similar papers in this journal
- A randomized sham-controlled trial of transcranial and intranasal photobiomodulation in Japanese patients with mild cognitive impairment and mild dementia due to Alzhimer’s disease: a protocol 92%
- Preliminary outcomes of combined treadmill and overground high-intensity interval training in ambulatory chronic stroke 91%
- Motivational Strategies for Stroke Rehabilitation: A Descriptive Cross-sectional Study 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.